TLR4 and pneumonia: Thus, our results suggest that S. salivarius-derived IA alleviates pneumonia by modulating macrophage inflammation through the TLR4 signaling pathway, offering a promising therapeutic strategy for pneumonia caused by P. aeruginosa.